Drug interaction study of JMKX003142 with amiodarone and febuxostat in healthy adults
Treatments studied
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a new drug, JMKX003142, interacts with two other medications (amiodarone and febuxostat) in healthy volunteers. The goal is to understand how these drugs affect each other in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy adults aged 18 to 45 years
- Body mass index (BMI) between 18 and 32, and weigh at least 99 pounds (45 kg)
- No major medical conditions or long-term health problems
- No allergies to the study drug or multiple other substances
- No history of heart rhythm problems or abnormal ECG readings
- Willing to use effective birth control from screening until 3 months after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new drug, VX-407, affects the levels of a combined oral contraceptive in your body. Participants must be healthy adults aged 18 to 65 with a certain body weight and BMI.
This study is testing a new investigational medicine called PYC-003 for people with autosomal dominant polycystic kidney disease (ADPKD). It is one of the first studies in humans, so the main goal is to see if the medicine is safe and tolerable. The study is for people with a specific genetic cause (PKD1 mutation) and with certain kidney imaging types.
This early-stage study tests how a new experimental drug (JMKX003142) interacts with other medications in healthy volunteers. Researchers want to understand whether taking this drug with other common drugs is safe and effective.
This study checks how a new drug interacts with the body. It is for healthy volunteers to see if the drug is safe and how it works in the body.
This study is for healthy Chinese men to see how the study drug JMKX003142 is processed in the body. You will take the drug by mouth and by vein on separate days to measure how much gets into your blood and how it leaves your body.
This trial tests whether a new drug, JMKX003142, affects the heart's electrical activity (QTc interval) in healthy volunteers. It helps determine if the drug is safe for the heart before testing in patients.
Hear when a new Autosomal Dominant Polycystic Kidney Disease (ADPKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.